Influence of water content in skin and transepidermal water loss on residual drug amount in used Fentos tape

Influence of water content in skin and transepidermal water loss on residual drug amount in used Fentos tape - Influence of water content in skin and transepidermal water loss on residual drug amount in used Fentos tape

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000023716

Enrollment

Registered

2016-08-22

Start date

2016-08-22

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cancer pain

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: The patients who are required for cancer pain control and are put on fentos tape

Exclusion criteria

Exclusion criteria: nothing

Design outcomes

Primary

Measure	Time frame
transepidermal water loss water content in corner residual of fentanyl citrate in used patches	—

Countries

Japan

Contacts

Public ContactReiko Teraoka

Kobe Pharmaceutical University Department of Pharmaceutical Technology

teraoka@kobepharma-u.ac.jp078-441-7531

Outcome results